Tomas Kalincik, Head of the Clinical Outcomes Research Unit at the University of Melbourne, explains his research comparing hematopoietic stem cell transplantation (HSCT) with existing treatments in relapsing and progressive MS.
<p><span data-sheets-value= "{"1":2,"2":"Read the related article in Neurology® "}" data-sheets-userformat= "{"2":13185,"3":{"1":0},"10":1,"11":4,"12":0,"15":"Calibri","16":12}"> Dr. Shuvro Roy talks with Dr. Matilde Inglese about comparing stem-cell transplants to DMTs in patien ... Show More